& Eckstein, A
After five half-lives, roughly 97% of a dose is gone: about 5 weeks for semaglutide, about 25 days for tirzepatide
Mitochondrial dysfunction is a common denominator linking skeletal muscle wasting due to disease, aging, and prolonged inactivity
Two-year data from the STEP 5 trial found that headache rates were identical between semaglutide and placebo by the end of the study, suggesting the excess headaches resolve as your body adjusts to the drug
The mechanisms of migraine are complex, involving many factors including serotonin and CGRP
Working with a clinician means: Any changes are spotted early Risks like sudden blood sugar spikes or rapid regain are reduced You have guidance on whether to stay off, restart, or adjust your dose In short, medical support gives you a safety net so youre not left guessing